Abstract
Background Analyses of correlates of SARS-CoV-2 infection or mortality have usually assessed individual predictors. This study aimed to determine if patterns of combined predictors may better identify risk of infection and mortality
Methods For the period of March 2nd to 10th 2020, the first 9 days of the COVID-19 pandemic in Indonesia, we selected all 18 confirmed cases, of which 6 died, and all 60 suspected cases, of which 1 died; and 28 putatively negative patients with pneumonia and no travel history. We recorded data for travel, contact history, symptoms, haematology, comorbidities, and chest x-ray. Hierarchical cluster analyses (HCA) and principal component analyses (PCA) identified cluster and covariance patterns for symptoms or haematology which were analysed with other predictors of infection or mortality using logistic regression.
Results For univariate analyses, no significant association with infection was seen for fever, cough, dyspnoea, headache, runny nose, sore throat, gastrointestinal complaints (GIC), or haematology. A PCA symptom component for fever, cough, and GIC tended to increase risk of infection (OR 3.41; 95% CI 1.06-14; p=0.06), and a haematology component with elevated monocytes decreased risk (OR 0.26; 0.07-0.79; 0.027). Multivariate analysis revealed that an HCA cluster of 3-5 symptoms, typically fever, cough, headache, runny nose, sore throat but little dyspnoea and no GIC tended to reduce risk (aOR 0.048; <0.001–0.52; 0.056). In univariate analyses for death, an HCA cluster of cough, fever and dyspnoea had increased risk (OR 5.75; 1.06 − 31.3, 0.043), but no other individual predictor, cluster or component was associated. Other significant predictors of infection were age ≥ 45, international travel, contact with COVID-19 patient, and pneumonia. Diabetes and history of contact were associated with higher mortality.
Conclusions Cluster groups and co-variance patterns may be stronger correlates of SARS-CoV-2 infection than individual predictors. Comorbidities may warrant careful attention as would COVID-19 exposure levels.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by grant award from the Directorate Research and Community Services Universitas Indonesia (PUTI Q1) to AJR.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was obtained from the Research Ethics Committee of the Faculty of Medicine, Universitas Indonesia-Dr. Cipto Mangunkusumo General Hospital, with approval number 20030331. After consideration of ethical issues, logistics and urgency of this work, the Committee waived the requirement for written individual informed consent and approved the sharing of anonymized data.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
List of abbreviations
- ACE-2
- angiotensin converting enzyme 2
- COVID-19
- Coronavirus disease 2019
- CT
- computed tomography
- GIC
- gastrointestinal complaints
- HCA
- hierarchical cluster analyses
- IQR
- interquartile range
- NIHRD
- National Institutes for Health Research and Development
- NLR
- neutrophil-to-lymphocyte ratio
- PCA
- principal component analyses
- RT-PCR
- real time polymerase chain reaction
- SARS-CoV-2
- Severe acute respiratory syndrome coronavirus 2
- SD
- standard deviation
- TB
- lung tuberculosis
